Injectable Dosage Injectable GHK-Cu is typically used for systemic effects or when topical delivery is insufficient: Standard range: 12 mg per injection, subcutaneous (SubQ) administration Common protocol: Daily or every-other-day injections, typically in 48 week cycles Concentration: Usually supplied as 10 mg/mL solution
Nat Rev Endocrinol 8:495502 Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Heise T, Bizzotto R et al (2016a) Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes
So a pH of 2 is 10 times less acidic than a pH of 1
Researchers also identified a dose response, meaning that the longer the patients took a GLP-1, the more likely they were to develop the condition
says, Trinity Meds changed my relationship with my body